The next-generation antibody therapeutics market, valued at US$ 9.09 billion in 2024, is expected to expand to US$ 22.88 billion by 2033, growing at a CAGR of 10.9% https://finance.yahoo.com/news/next-generation-antibody-therapeutics-market-140100082.html